NM_000540.3:c.9472+30C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000540.3(RYR1):​c.9472+30C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.065 in 1,598,026 control chromosomes in the GnomAD database, including 3,745 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 281 hom., cov: 32)
Exomes 𝑓: 0.066 ( 3464 hom. )

Consequence

RYR1
NM_000540.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -5.49

Publications

5 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • RYR1-related myopathy
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 19-38512513-C-T is Benign according to our data. Variant chr19-38512513-C-T is described in ClinVar as [Benign]. Clinvar id is 256583.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.111 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR1NM_000540.3 linkc.9472+30C>T intron_variant Intron 63 of 105 ENST00000359596.8 NP_000531.2 P21817-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR1ENST00000359596.8 linkc.9472+30C>T intron_variant Intron 63 of 105 5 NM_000540.3 ENSP00000352608.2 P21817-1

Frequencies

GnomAD3 genomes
AF:
0.0550
AC:
8366
AN:
152176
Hom.:
281
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0341
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0474
Gnomad ASJ
AF:
0.0579
Gnomad EAS
AF:
0.00635
Gnomad SAS
AF:
0.119
Gnomad FIN
AF:
0.0857
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0639
Gnomad OTH
AF:
0.0630
GnomAD2 exomes
AF:
0.0671
AC:
16140
AN:
240568
AF XY:
0.0699
show subpopulations
Gnomad AFR exome
AF:
0.0314
Gnomad AMR exome
AF:
0.0711
Gnomad ASJ exome
AF:
0.0478
Gnomad EAS exome
AF:
0.00262
Gnomad FIN exome
AF:
0.0865
Gnomad NFE exome
AF:
0.0662
Gnomad OTH exome
AF:
0.0599
GnomAD4 exome
AF:
0.0660
AC:
95448
AN:
1445732
Hom.:
3464
Cov.:
32
AF XY:
0.0678
AC XY:
48781
AN XY:
719978
show subpopulations
African (AFR)
AF:
0.0342
AC:
1142
AN:
33364
American (AMR)
AF:
0.0677
AC:
3027
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0504
AC:
1316
AN:
26094
East Asian (EAS)
AF:
0.0123
AC:
486
AN:
39658
South Asian (SAS)
AF:
0.118
AC:
10171
AN:
86148
European-Finnish (FIN)
AF:
0.0812
AC:
3517
AN:
43290
Middle Eastern (MID)
AF:
0.0697
AC:
401
AN:
5750
European-Non Finnish (NFE)
AF:
0.0648
AC:
71744
AN:
1106596
Other (OTH)
AF:
0.0606
AC:
3644
AN:
60120
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
4903
9806
14709
19612
24515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2686
5372
8058
10744
13430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0550
AC:
8372
AN:
152294
Hom.:
281
Cov.:
32
AF XY:
0.0568
AC XY:
4227
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0341
AC:
1416
AN:
41562
American (AMR)
AF:
0.0476
AC:
728
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0579
AC:
201
AN:
3472
East Asian (EAS)
AF:
0.00637
AC:
33
AN:
5184
South Asian (SAS)
AF:
0.119
AC:
573
AN:
4826
European-Finnish (FIN)
AF:
0.0857
AC:
910
AN:
10616
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0639
AC:
4347
AN:
68016
Other (OTH)
AF:
0.0633
AC:
134
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
414
827
1241
1654
2068
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0572
Hom.:
55
Bravo
AF:
0.0501
Asia WGS
AF:
0.0690
AC:
240
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Oct 28, 2013
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.019
DANN
Benign
0.67
PhyloP100
-5.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77374921; hg19: chr19-39003153; COSMIC: COSV62114812; API